tiprankstipranks
Ainos Inc (AIMD)
:AIMD
US Market
Holding AIMD?
Track your performance easily

Ainos (AIMD) Stock Price & Analysis

65 Followers

AIMD Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

11.08%0.16%0.32%88.43%
11.08% Insiders
0.32% Other Institutional Investors
88.43% Public Companies and
Individual Investors

AIMD FAQ

What was Ainos Inc’s price range in the past 12 months?
Ainos Inc lowest stock price was $0.40 and its highest was $3.10 in the past 12 months.
    What is Ainos Inc’s market cap?
    Ainos Inc’s market cap is $9.16M.
      When is Ainos Inc’s upcoming earnings report date?
      Ainos Inc’s upcoming earnings report date is Mar 28, 2025 which is in 68 days.
        How were Ainos Inc’s earnings last quarter?
        Ainos Inc released its earnings results on Nov 06, 2024. The company reported -$0.328 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.328.
          Is Ainos Inc overvalued?
          According to Wall Street analysts Ainos Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Ainos Inc pay dividends?
            Ainos Inc does not currently pay dividends.
            What is Ainos Inc’s EPS estimate?
            Ainos Inc’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Ainos Inc have?
            Ainos Inc has 14,086,326 shares outstanding.
              What happened to Ainos Inc’s price movement after its last earnings report?
              Ainos Inc reported an EPS of -$0.328 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4%.
                Which hedge fund is a major shareholder of Ainos Inc?
                Currently, no hedge funds are holding shares in AIMD
                ---

                Company Description

                Ainos Inc

                Amarillo Biosciences, Inc. engages in developing biologics for the treatment of human and animal diseases. It focuses on research aimed at the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon alpha that is administered in a proprietary low dose oral form. The company was founded by Joseph M. Cummins in June 1984 and is headquartered in Amarillo, TX.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Aditxt, Inc.
                Anixa Biosciences
                Avalo Therapeutics
                Cyclacel Pharmaceuticals
                AngioDynamics
                Veeva Systems
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis